Bitter Melon https://greenmedinfo.com/category/keywords/Bitter%20Melon en Potential use of bitter melon derived compounds as antidiabetics. https://greenmedinfo.com/article/potential-use-bitter-melon-derived-compounds-antidiabetics n/a PMID:  Pathophysiology. 2018 May 12. Epub 2018 May 12. PMID: 29764719 Abstract Title:  Potential use of bitter melon (Momordica charantia) derived compounds as antidiabetics: In silico and in vivo studies. Abstract:  Momordica charantia (bitter lemon) belongs to the cucurbitaceae family which has been extensively used in traditional medicines for the cure of various ailments such as cancer and diabetes. The underlying mechanism of M. charantia to maintain glycemic control was investigated. GLP-1 and DPP-4 gene modulation by M. charantia (5-20% inclusion in rats diet) was investigated in vivo by RT-PCR and possible compounds responsible for diabetic action predicted through in silico approach. Phytochemicalss previously characterized from M. charantia were docked into glucacon like peptide-1 receptor (GLP-1r), dipeptidyl peptidase (DPP4) and Takeda-G-protein-receptor-5 (TGR5) predicted using Autodock Vina. The results of the in silico suggests momordicosides D (ligand for TGR5), cucurbitacin (ligand for GLP-1r) and charantin (ligand for DPP-4) as the major antidiabetic compounds in bitter lemon leaf. M. charantia increased the expression of GLP-1 by about 295.7% with concomitant decreased in expression of DPP-4 by 87.2% with 20% inclusion in rat's diet. This study suggests that the mechanism underlying the action of these compounds is through activation of TGR5 and GLP-1 receptor with concurrent inhibition of DPP4. This study confirmed the use of this plant in diabetes management and the possible bioactive compounds responsible for its antidiabetic property are charantin, cucurbitacin and momordicoside D and all belong to the class of saponins. https://greenmedinfo.com/article/potential-use-bitter-melon-derived-compounds-antidiabetics#comments Bitter Melon Diabetes Mellitus: Type 2 Bitter Melon Diabetes mellitus: Type 2 In Vitro Study Wed, 06 Jun 2018 00:33:44 +0000 greenmedinfo 165313 at https://greenmedinfo.com